Ginkgo Bioworks Holdings Inc. (DNA)
NYSE · Healthcare
Ginkgo Bioworks Holdings Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 170.2M | 227.0M | 251.5M | 477.7M | 313.8M | 76.7M | 54.2M |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -315.3M | -559.8M | -864.4M | -2.21B | -1.83B | -137.0M | -71.6M |
| EBITDA | -256.3M | -496.7M | -793.9M | -2.17B | -1.80B | -123.2M | -60.8M |
| Net Income | -312.8M | -547.0M | -892.9M | -2.10B | -1.83B | -126.6M | -119.3M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 55M | 52M | 49M | 42M | 1,360M | 1,275M | 1,149M |
Ginkgo Bioworks Holdings Inc. Income Statement — FAQ
Ginkgo Bioworks Holdings Inc. (DNA) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNA's income statement history?
The chart and table above show Ginkgo Bioworks Holdings Inc.'s income statement by year and by quarter, including the growth rate.